Results 21 to 30 of about 2,175,311 (150)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

open access: yesJournal of Diabetes Research, 2016
Cardiovascular disease (CVD) is one of the most severe diseases in clinics. Fibroblast growth factor 21 (FGF21) is regarded as an important metabolic regulator playing a therapeutic role in diabetes and its complications.
Peng Cheng   +9 more
doaj   +1 more source

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

open access: yesScientific Reports, 2021
Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress.
Suvanjaa Sivalingam   +14 more
doaj   +1 more source

Sequence features of retrotransposons allow for epigenetic variability

open access: yeseLife, 2021
Transposable elements (TEs) are mobile genetic elements that make up a large fraction of mammalian genomes. While select TEs have been co-opted in host genomes to have function, the majority of these elements are epigenetically silenced by DNA ...
Kevin R Costello   +6 more
doaj   +1 more source

Can Weight Loss Improve the Cardiovascular Outcomes of Patients with Obesity and Obstructive Sleep Apnea?

open access: yesHearts, 2022
Cardiovascular events are the primary cause of mortality in patients with obstructive sleep apnea and obesity. The rising prevalence of obstructive sleep apnea in recent decades has been linked to increasing rates of obesity.
Ayyad Alruwaily   +3 more
doaj   +1 more source

Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells

open access: yesNature Communications, 2017
The repertoire of tissue-specific distal regulators of gene transcription enhancers defines homeostasis or disease. Here, the authors reveal the enhancer and super-enhancer signature of vascular smooth muscle cells under normal and angiotensin II stimuli,
Sadhan Das   +13 more
doaj   +1 more source

Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes

open access: yesMolecular Metabolism, 2021
Background: Insulin has been demonstrated to exert direct and indirect effects on vascular tissues. Its actions in vascular cells are mediated by two major pathways: the insulin receptor substrate 1/2-phosphoinositide-3 kinase/Akt (IRS1/2/PI3K/Akt ...
Jialin Fu   +4 more
doaj   +1 more source

Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes

open access: yesHeliyon, 2022
Changes in cellular bioenergetics such as mitochondrial respiration and glycolysis may play a role in the pathogenesis of various diseases including type 1 diabetes (T1D).
Joana Mendes Lopes de Melo   +7 more
doaj   +1 more source

RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice

open access: yesMolecular Medicine, 2017
Epidemiological studies have suggested a link between cumulative diabetic exposure and cancer. The interaction of advanced glycation end products (AGEs) with their receptor (RAGE) may contribute to the phenomenon.
Nobutaka Nakamara   +6 more
doaj   +1 more source

Murine Nephrotoxic Nephritis as a Model of Chronic Kidney Disease

open access: yesInternational Journal of Nephrology, 2018
Using the nonaccelerated murine nephrotoxic nephritis (NTN) as a model of chronic kidney disease (CKD) could provide an easily inducible model that enables a rapid test of treatments.
M. K. E. Ougaard   +5 more
doaj   +1 more source

Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development

open access: yesCells, 2022
Type 1 diabetes (T1D) is an autoimmune disease in which the β-cells of the pancreas are attacked by the host’s immune system, ultimately resulting in hyperglycemia. It is a complex multifactorial disease postulated to result from a combination of genetic
Chenping Du   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy